Results 1 to 10 of about 10,129 (241)
EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS [PDF]
Revista do Instituto de Medicina Tropical de São Paulo, 2015 SUMMARY The epidemiological characteristics of paracoccidioidomycosis were reviewed and updated. The new endemic areas in Brazil were discussed in the section regarding the geographic distribution of the mycosis.
R. Martinez
semanticscholar +7 more sources
Factors influencing treatment adherence in paracoccidioidomycosis in Brazil
Public Health Challenges, 2023 Introduction Paracoccidioidomycosis is a systemic mycosis endemic to Latin America, with frequent reports of poor treatment adherence resulting in worse clinical outcomes.
Wdson Luis Lima Kruschewsky +7 more
doaj +2 more sources
Serological diagnosis of paracoccidioidomycosis in HIV-coinfected patients [PDF]
Memorias do Instituto Oswaldo Cruz, 2010 Paracoccidioidomycosis should be differentiated from other opportunistic diseases in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients who live in Latin America.
BELLISSIMO-RODRIGUES, Fernando +2 more
core +4 more sources
Paracoccidioidomycosis Protective Immunity [PDF]
Journal of Fungi, 2021 Protective immunity against Paracoccidioides consists of a stepwise activation of numerous effector mechanisms that comprise many cellular and soluble components.
E. Burger
semanticscholar +4 more sources
Serology of paracoccidioidomycosis [PDF]
Mycopathologia, 2008 This review provides the background for understanding the role of a battery of diagnostic methods in paracoccidioidomycosis (PCM). This systemic mycosis is a disease endemic in many regions of Latin America, with sporadic cases also occurring throughout ...
Camargo, Zoilo Pires de
core +5 more sources
Neoplasia and paracoccidioidomycosis [PDF]
Mycopathologia, 2008 Published studies on the association between cancer and paracoccidioidomycosis consist either isolated cases or clinical data based on hospital cohorts of paracoccidioidomycosis. The frequency of neoplasia in series of > or = 80 patients with paracoccidioidomycosis ranges from 0.16 to 14.1%, mean of 3.96%.
Maria Aparecida Shikanai‐Yasuda +5 more
openalex +4 more sources
Revista da Sociedade Brasileira de Medicina Tropical, 2018 Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment.
L. Covre +4 more
semanticscholar +3 more sources
Treatment compliance of patients with paracoccidioidomycosis in Central-West Brazil
Jornal Brasileiro de Pneumologia, 2019 Objective: To evaluate the treatment compliance of patients with paracoccidioidomycosis. Methods: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to ...
Ú. V. Andrade +7 more
semanticscholar +3 more sources
Revista do Instituto de Medicina Tropical de São Paulo, 1994 FRANCO, Marcello +3 more
doaj +9 more sources
Regulatory T cells in paracoccidioidomycosis [PDF]
Virulence, 2018 This review addresses the role of regulatory T cells (Tregs), which are essential for maintaining peripheral tolerance and controlling pathogen immunity, in the host response against Paracoccidioides brasiliensis, a primary fungal pathogen.
V. Calich, R. Mamoni, F. V. Loures
semanticscholar +5 more sources